CJ Cheiljedang set to acquire Batavia Biosciences for $226m
WEBNov 8, 2021 · A leading producer of lysine for animal feed, CJ Cheiljedang said its board backed the proposed acquisition of a 75.8% stake in Netherlands-based Batavia Biosciences for 267.7bn won ($226m or €195.3m), according to Korean media coverage , citing a regulatory filing by the firm.. CJ Cheiljedang said it will purchase 50,807 shares in Batavia including 13,007 new shares, at €3,844 euros per ...
GE Healthcare Life Sciences completes transition into Cytiva
WEBApr 1, 2020 · Now, with the deal complete, GE Healthcare Life Sciences has emerged at the other side rebranded as Cytiva. The company will retain the same staff, which means that it will have 7,000 employees and possess operations in 40 countries, becoming part of Danaher Corporation Life Sciences platform. CEO and president of Cytiva, Emmanuel Ligner, spoke ...
Lonza invests in Singapore to support growth in mammalian …
WEBOct 11, 2021 · Lonza is investing to expand mammalian development services at its Singapore facility; the move will bring additional capacity for cell culture, purification, and analytical services for mammalian biologics. The addition of new technology, alongside the increase in capacity and headcount of the development services team in Singapore, will ...
Fujifilm to invest $1.6bn and make its Hillerød facility in Denmark …
WEBJun 30, 2022 · Almost all of the investment will be ploughed into FDB's site in Hillerød, Denmark, which Fujifilm acquired from Biogen in August 2019.. Some 450 jobs will be created at the Danish campus, to add to the 1,055 …
Building a biotech hub: Switzerland focuses on mRNA, CGT and …
WEBSep 8, 2021 · There are 314 biotech companies in Switzerland: broken down into 251 developers and 63 suppliers. Swiss life science exports were valued at CHF 99.1bn ($108bn USD) in 2020 and accounted for 44% of total exports. The sector has grown by a factor of 4.5 since 2000, when life sciences accounted for 17% of …
RoslinCT and Lykan Bioscience combine to create advanced cell …
WEBAug 4, 2022 · News and analysis on the clinical development and manufacture of large molecule drugs. Edinburgh CDMO RoslinCT and Massachusetts CDMO Lykan Bioscience will combine to create a global advanced therapies CDMO: offering significantly expanded manufacturing capacity. The combined group will offer process development expertise and cGMP manufacturing ...
Spend, spend, spend: How biopharma consumable suppliers …
WEBNov 17, 2021 · The company, which strengthened its presence in bioprocessing through the acquisition of GE’s biopharma unit, provides a wide range of consumables such as single-use systems through brands including Cytivia and Pall. In September, Thermo Fisher revealed plans to invest $1bn from 2020 to 2022 to expand its bioproduction capacity.
Bio International Convention 2022: Program highlights
WEBJun 1, 2022 · The 2022 BIO International Convention will feature 100+ interactive sessions across 4 days covering a variety of therapeutic areas, business development, digital health, patient advocacy, public policy, and next-generation biotherapeutics, and the latest updates from industry experts on COVID-19. The program will be delivered in person at the ...
Fujifilm to acquire US-based recombinant protein maker
WEBMar 22, 2022 · Fujifilm Irvine Scientific, Inc, has announced the acquisition of Shenandoah Biotechnology, a company supplying recombinant proteins to the drug discovery, life science research, and cell and gene therapy markets. The type of recombinant proteins that the Pennsylvania based, privately held company manufactures include …
Boehringer Ingelheim inaugurates Vienna production facility
WEBOct 11, 2021 · Roche’s Actemra/RoActemra approved for treatment of severe COVID-19 in the EU. Chinook Therapeutics creates JV for kidney disease therapies in China. Boehringer Ingelheim has inaugurated a state-of-the-art biopharmaceutical production facility in Vienna, Austria: representing the single largest investment in the company’s history.
Skip to content